Replies to post #127693 on BioAmber Inc (fka BIOAQ)

[Real McCoy]

What do you say we go by the last ever comment from the company filed with the SEC. Deal?

[TheRealMrPirate]

Bingo, SEC filings is where you'd find your change of control.
On that note, can you post the SEC filing for the newly appointed directors of Bioamber? We'd be grateful...or a Q filing, we'd all love to see Bioamber's financial health? Or a....etc.... Who's running Bioamber now, who's steering the ship? Must be a SEC filing for that no ?
An asset sale is an asset sale, whether it's in a liquidation scenario or not, it's still an asset sale. The company was stripped of it's assets in Chapter 15 bankruptcy. The equity was not acquired, the shares were not acquired, the board of directors / all management were dismissed.
You did not get a proxy, nor did you vote for new directors to be appointed to the board for a change of control to occur. There was no plan of arrangement filed with the court before the termination of proceedings & there was no change of control, the former company named "Bioamber is out of business & Delaware 4612067 no longer owns the trade name "Bioamber" - clearly documented on court papers.
There was no change of control, shares would have been acquired. This 'was' a publicly listed company, you as a shareholder would have voted on it & there would have been multiple SEC filings for the event.

[Brucebannerr]

Bawhahaha, of course there is always the last sec . filing from the dead company the worthless shares are attached too.
On October 22, 2018, the Company completed the sale of certain of its assets to LCY Biotechnology Inc. (previously 9384-3076 Québec Inc.). These assets comprised all of the Company’s assets, save and except for the cash, accounts receivable and inventory of the Company, and also excluded certain U.S. based office equipment. The purchaser did not seek the assignment of the Company’s contracts, which meant that certain intellectual property under license from third parties was also not transferred to the purchaser.

This transaction was approved by the Quebec Superior Court of Justice on September 18, 2018, and by the United States Bankruptcy Court for the District of Delaware on October 9, 2018. The liquidation of the Company’s assets will result in little to no residual value for non-secured creditors, and no residual value for equity investors of the Company.
Love that last paragraph.